Heart groups in South Africa advocate for tighter LDL-C control and lipoprotein(a) testing to curb atherosclerotic cardiovascular disease

Authors

  • E Q Klug Cardiologist, Netcare Sunninghill and Sunward Park hospitals, Johannesburg, South Africa; School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and Division of Cardiology, Charlotte Maxeke Johannesburg Academic Hospital, South Africa https://orcid.org/0000-0002-5798-478X
  • F J Raal Director, Carbohydrate and Lipid Metabolism Research Unit, University of the Witwatersrand, Johannesburg, South Africa; and Division of Endocrinology and Metabolism, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

DOI:

https://doi.org/10.7196/SAMJ.2024.v114i5.1973

Keywords:

LDL-C GOALS , ORAL AND SUBCUTANEOUS THERAPY, Lp(a) risk modifier

Abstract

-

References

Boren J, Chapman MJ, Krauss RM, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2020;41(24):2313-2330. https://doi.org/10.1093/eurheartj/ehz962

Mach F, Baigent C, Catapano AL, et al. ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2020;41(1):111-188. https://doi.org/10.1093/ eurheartj/ehz455

Klug E, Raal FJ, Marais AD, et al. South African Dyslipidaemia Guideline Consensus Statement 2018. S Afr Med J 2018;108(Part 2):973-997. https://doi.org/10.7196/SAMJ.2018.v108i11.13383

Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease

and aortic stenosis: A European Atherosclerosis Society consensus statement. Eur Heart J

;43(39):3925-3946. https://doi.org/10.1093/eurheartj/ehac361

ViraniSS,BrautbarA,DavisBC,etal.Associationsbetweenlipoprotein(a)levelsandcardiovascular

outcomes in black and white subjects: The atherosclerosis risk in communities (ARIC) study. Circulation 2012;125(2):241-249. https://doi.org/10.1161%2FCIRCULATIONAHA.111.045120

Downloads

Published

2024-05-09

Issue

SAMJ Vol. 114 No. 5

Section

Correspondence

License

Copyright (c) 2024 E Q Klug, F J Raal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Licensing Information

The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited. 

Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository. 

Publishing Rights

Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.

 

How to Cite

1.
Klug EQ, Raal FJ. Heart groups in South Africa advocate for tighter LDL-C control and lipoprotein(a) testing to curb atherosclerotic cardiovascular disease. S Afr Med J [Internet]. 2024 May 9 [cited 2025 Sep. 26];114(5):e1973. Available from: https://samajournals.co.za/index.php/samj/article/view/1973